Potential Impact of COVID-19 on Single-Photon Emission Computed Tomography to Remain Lucrative During 2019-2026 – Jewish Life News

Global Single-Photon Emission Computed Tomography Market Analysis

The recent report presented by MRRSE on the global Single-Photon Emission Computed Tomography market is an in-depth analysis of the overall prospects of the Single-Photon Emission Computed Tomography market in the upcoming years. The data collected from credible primary and secondary sources is accurately represented in the report backed up by relevant figures, graphs, and tables. The market study covers the impact of the COVID-19 pandemic on the growth prospects of the global Single-Photon Emission Computed Tomography market. The report includes a quantitative and qualitative analysis of the various aspects of the market by collecting data from the key participants in the Single-Photon Emission Computed Tomography market value chain.

The report reveals that the global Single-Photon Emission Computed Tomography market is set to grow at a CAGR of ~XX% over the forecast period (2019-2029) and surpass the value of ~US$XX by the end of 2029. The presented study also includes a thorough analysis of the micro and macroeconomic factors, regulatory framework, and current trends that are expected to influence the growth of the Single-Photon Emission Computed Tomography market during the assessment period.

Request Sample Report @https://www.mrrse.com/sample/14899?source=atm

Vital Information Enclosed in the Single-Photon Emission Computed Tomography Market Report:

Important Queries Addressed in the Report

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/14899?source=atm

Single-Photon Emission Computed Tomography Market Segmentation

The market study put forward by MRRSE segments the global Single-Photon Emission Computed Tomography market to offer a microscopic understanding of the various aspects of the Single-Photon Emission Computed Tomography market. The Single-Photon Emission Computed Tomography market is segmented on the basis of region, product type, end-user, and more.

The study offers a Y-o-Y growth projection of each market segment and sub-segment over the stipulated timeframe of the study.

Insufficient supply of molecular isotopes and lack of trained and skilled specialists and professionals are the biggest obstacles in the growth of the global SPECT market

Diagnostic imaging devices require molecular isotopes, however the lack of availability and insufficient supply of molecular isotopes is likely to act as a restraint in the growth of theglobal SPECT marketduring the forecast period. For example, two chemical elements such as technetium and molybdenum that generally fuel a large number of SPECT procedures in cardiology have been facing numerous disruptions in supply over the past few years. Another reason responsible for hampering the supply of molecular isotopes is that the reactors supplying molecular isotopes got shut down permanently in Canada owing to reasons related to safety concerns.

Product recalls is another factor that is creating a negative impact on the worldwide market for SPECT. The use of SPECT devices in diagnosis, staging, restaging and follow up on lesions, diseases and organ dysfunctions, diseases such as cancer, cardiovascular disease and brain dysfunction are associated with adverse effects. Owing to product recalls on account of the adverse effects of SPECT devices the global SPECT market is facing challenges in terms of revenue growth. Poor health care systems especially in developing countries and in countries in the Eastern European region are also expected to restrain the growth of the global SPECT market during the period of study. Lack of basic health care services is anticipated to have an adverse impact on the global market. Lack of funds for advanced health care facilities is another factor that is hampering revenue growth of the global SPECT market.

In order to achieve better imaging capabilities and to offer accurate information related to organ functions and dysfunctions, radioisotope tracers are used by diagnostic and imaging devices. The radioisotope tracer Technetium-99m is widely preferred in SPECT imaging. However, radioisotope tracers have a half-life of just about six hours, and this limits the usage of these tracers in the diagnostic imaging industry. This factor has decreased the popularity of SPECT imaging, thereby negatively impacting the global SPECT market.

Top application areas of SPECT, SPECT-CT and SPECT-MRI imaging devices

SPECT is a powerful nuclear medicine technique that allows non-invasive diagnostic imaging of the metabolic process using short lived radioisotopes thus generating 3-D images of functional processes in the human body. There are numerous applications of SPECT scanners in the global market. One of the main uses of SPECT imaging is in the detection of chronic disorders.

Cardiology

SPECT can be used to assess the extent of cardiovascular disease. SPECT helps in identifying patients who are likely to benefit from heart bypass surgery. SPECT imaging is also used for the diagnosis of ischemic heart disease. Cardiology is a relatively mature application area in the global SPECT market.

Oncology

SPECT imaging is useful in the staging and restaging of malignant tumors. It also helps in locating the best site for biopsy of a suspected tumor.

Neurology

SPECT is used to diagnose, plan treatment and predict outcomes in various neurological disease states by monitoring the effects of therapy either with the help of radiation or chemotherapy or both.

Cardiology and Oncology are the top two application segments in the global SPECT market in terms of revenue share. However, the Neurology segment is expected to grow at the fastest rate of 7.9% during the forecast period. Cardiology and Oncology are the most attractive segments by application in the global SPECT market, with a market attractiveness index of 1.4.

Buy This Report @ https://www.mrrse.com/checkout/14899?source=atm

Why Buy from MRRSE?

Continued here:
Potential Impact of COVID-19 on Single-Photon Emission Computed Tomography to Remain Lucrative During 2019-2026 - Jewish Life News